Board of Suven Life Sciences approves allotment of 181 cr equity shares on conversion of warrants

2 Apr 2022 , 01:33 AM

Suven Life Sciences announced that the Board of Directors of the company at its meeting held on 28 March 2022 has approved the allotment of 181 crore equity shares on conversion of equivalent number of convertible warrants Consequently the paid up equity share capital has increased to 145382478 equity shares of Re 1 each